OHC Evaluating New Treatment for Older Adults with Hodgkin Lymphoma
September 10, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com Survival rates for patients with Hodgkin lymphoma have improved in the past few decades, largely due to (Read More)
OHC Doctors Warn Thirty-somethings: Be Aware of Testicular Cancer
September 1, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com Testicular cancer is one of the most commonly diagnosed cancers in young adult men, particularly between ages 30 (Read More)
OHC doctors are the first in the U.S. to use newly FDA-approved treatment for patients with lymphoma.
August 31, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma in adults worldwide. It (Read More)
OHC Is Helping Raise Awareness of Ovarian Cancer
August 31, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com September is Ovarian Cancer Awareness Month and, as a sponsor of the Ovarian Cancer Alliance of Greater (Read More)
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com Multiple myeloma is a type of blood cancer for which there is no cure. In 2020, of all patients newly diagnosed (Read More)
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, Marketing & Physicians Services 513-751-2145 x10143 Joan.manzo@usoncology.com Henry Picagli never expected to be sharing such a personal story with others, but after a near-death episode and a (Read More)
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com There are many things we can do to reduce our risk of developing cancer. Eat a healthy, well-balanced diet. Make (Read More)
Local Doctors Are Among a Select Few Nationally to Evaluate the Expanded Use of a Ground-breaking Cancer Treatment
July 24, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com The adult cancer experts at OHC are offering a new beacon of hope to cancer patients who are running out of (Read More)
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com Today, lung cancer remains the leading cancer cause of death in the U.S. for both men and women. And OHC is (Read More)
OHC Researchers are Evaluating a New Combination of Drugs for HER2-positive Breast Cancer
June 17, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com Breast cancer remains the second leading cause of cancer death in women (lung cancer remains the first). A form (Read More)
OHC once again receives 3-year certification by the Quality Oncology Practice Initiative Certification Program
August 19, 2019
FOR IMMEDIATE RELEASE Contact: Joanie Manzo 513-751-2145 joan.manzo@usoncology.com With an impressive score of 100%, OHC once again received 3-year certification by the Quality Oncology Practice Initiative Certification Program (QOPI) of the American (Read More)
Brain Tumor Center is First in the Eastern U.S. to Offer Targeted GammaTile™ Therapy for Recurrent Brain Tumors
August 15, 2019
FOR IMMEDIATE RELEASE Contact: Joanie Manzo 513-751-2145 joan.manzo@usoncology.com OHC is pleased to share that the Brain Tumor Center at The Jewish Hospital – Mercy Health is the first hospital in the eastern U.S. to offer GammaTile™ (Read More)
FOR IMMEDIATE RELEASE August 14, 2019 Contact: Joanie Manzo OHC Marketing 513-751-2145 joan.manzo@usoncology.com OHC is pleased to share that the Brain Tumor Center at The Jewish Hospital – Mercy Health has earned The Joint Commission’s Gold Seal (Read More)
OHC and Patient Power host a free, community event for CLL patients and their care partners in Cincinnati, Ohio
July 17, 2019
On Saturday, July 27, Patient Power, an organization devoted to empowering cancer patients through information, will be hosting a free community event in Cincinnati, Ohio for chronic lymphocytic leukemia (CLL) patients. The panelists will include (Read More)
OHC Receives 2019 Excellence in Oncology Award
May 31, 2019
FOR IMMEDIATE RELEASE Contact: Joanie Manzo 513-546-9597 Joan.manzo@usoncology.com Congratulations to the entire team at OHC who has been named a recipient of a 2019 Excellence in Oncology Award from Oncology Times. OHC received Honorable (Read More)
